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Background
Both midwall and infarction-related fibrosis affect prog-
nosis in patients with aortic stenosis. CMR remains the
gold standard for identification of replacement fibrosis,
however its use can be limited by patient suitability, cost
and availability. We sought to develop a clinical model
to identify the presence of fibrosis (midwall or infarc-
tion) based on variables from patient demographics, bio-
marker and imaging parameters which could potentially
be applied easily in the outpatient setting.
Methods
113 patients with moderate or severe aortic stenosis (age
78 [70, 83]; 71% males, average peak aortic valve gradient
59 mmHg) underwent transthoracic echocardiography to
assess the severity of stenosis and CMR to determine the
presence of midwall fibrosis or infarction. Forward step-
wise selection was used to find the optimal logistic regres-
sion model to predict fibrosis from 91 potential predictors.
This multivariable model was used to assign predicted
probabilities of fibrosis to each patient, and checked using
the Hosmer-Lemeshow goodness-of-fit test and the AUC
statistic. The model was finally internally validated using a
bootstrap method.
Results
In a multivariable model, platelet count, urea, LVEF
(based on CMR) and NT-ProBNP remained significant.
The final multivariable model was used to develop a
clinical prediction model to assign a predicted probabil-
ity of fibrosis to each patient. This was based on the
three biomarkers and the LVEF. A histogram of these
probabilities can be seen in figure 1, divided by whether
the patients did or did not actually have fibrosis.
Depending on the clinical setting, the information
required and the probability cut-off chosen, the model
can have sensitivity or specificity exceeding 90%.
A Hosmer-Lemeshow goodness-of-fit test was used to
check the calibration of the model and there was no evi-
dence that the model was badly calibrated (p=0.44). The
AUC was 0.86, suggesting good discrimination. A boot-
strap method was used to internally validate the discri-
mination of the model and the bias was estimated to be
3.9% (95% CI 0.2% -9.9%) suggesting only a small
amount of bias.
Conclusions
A clinical model to predict the presence or absence of
fibrosis using simple clinical parameters is possible and
can be used to risk-stratify patients easily in the outpati-
ent setting.
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Figure 1 Using the model based on the platelet count, urea level, NT-Pro BNP level and LVEF the probability of any fibrosis can be
calculated for each patient. Depending on the clinical setting the model allows for variable cut-off values to adjust sensitivity and specificity
according to clinical requirements. For example, a probability cut-off of 0.50 will give 90% sensitivity of predicting any fibrosis with 55%
specificity; whereas a cut-off value of 0.90 will give 50% sensitivity with a specificity of 93%.
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